|
Index of reports
> Disability (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trileptal (Oxcarbazepine) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Trileptal side effects in 11 year old male
Reported by a physician from China on 2012-07-20
Patient: 11 year old male
Reactions: Myoclonus, Leukodystrophy, Tremor
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Trileptal
Administration route: Oral
Indication: Epilepsy
Start date: 2011-11-24
Trileptal
Dosage: 0.45 g, bid
Administration route: Oral
End date: 2012-05-29
Other drugs received by patient: Lamotrigine; Valproate Sodium
Possible Trileptal side effects in 11 year old male
Reported by a physician from China on 2012-06-11
Patient: 11 year old male
Reactions: Myoclonus, Leukodystrophy, Tremor
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Trileptal
Dosage: 0.45 g, bid
Administration route: Oral
End date: 2012-05-29
Trileptal
Administration route: Oral
Indication: Epilepsy
Start date: 2011-11-24
Other drugs received by patient: Lamotrigine; Valproate Sodium
Possible Trileptal side effects in male
Reported by a consumer/non-health professional from Mexico on 2012-04-18
Patient: male
Reactions: Diabetes Mellitus, Pain, Poor Peripheral Circulation, Extremity Necrosis
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Trileptal
Other drugs received by patient: Insulin
Possible Trileptal side effects in male
Reported by a consumer/non-health professional from United States on 2012-02-02
Patient: male
Reactions: Bedridden, Head Injury, Abasia, Fall, Onychomadesis, Loss of Consciousness, Limb Injury, Drug Withdrawal Convulsions, Withdrawal Syndrome, Back Injury
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Trileptal
Possible Trileptal side effects in male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-01-17
Patient: male
Reactions: Dyspnoea, Interstitial Lung Disease, Oxygen Saturation Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Valproate Sodium
Administration route: Oral
Indication: Epilepsy
Trileptal
Dosage: 750 mg and 650 mg daily
Administration route: Oral
Indication: Epilepsy
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Zyprexa; Paroxetine HCL
Possible Trileptal side effects in male
Reported by a physician from Sweden on 2011-12-02
Patient: male
Reactions: Fatigue, Disturbance in Attention, Mood Swings, Epilepsy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Trileptal
Other drugs received by patient: Valproate Sodium
Possible Trileptal side effects in male
Reported by a physician from France on 2011-11-15
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Lymphadenopathy, Blood Creatine Phosphokinase Increased, Respiratory Disorder, High Density Lipoprotein Increased, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Dermatitis Bullous, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Cough, Back Pain, Medical Device Complication, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Renal Colic, Corneal Neovascularisation, Skin Exfoliation, Eye Discharge, Scab, Symblepharon, Nephrolithiasis, Photophobia, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Cataract, Epilepsy, Iris Adhesions, Alopecia, Lacrimation Decreased, Gait Disturbance, Asthenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Depakene
Dosage: 1 g daily
Administration route: Oral
Indication: Partial Seizures
Start date: 2004-11-23
End date: 2004-11-23
Trileptal
Dosage: 600 mg, bid
Administration route: Oral
Indication: Partial Seizures
Start date: 2005-02-14
End date: 2005-02-21
Depakene
Dosage: 1.5 g daily
Start date: 2004-11-24
End date: 2005-02-21
Depakene
Dosage: 1.6 g daily
Indication: Partial Seizures
End date: 2004-11-22
Aspegic 325
Indication: Influenza Like Illness
Start date: 2005-02-01
Other drugs received by patient: Levetiracetam; Clobazam; Topiramate; Clonazepam
|
